THE DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF IRON DEFICIENCY ANEMIA IN ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR DISEASES

Rustamov Jamol Istamovich; Nurbayev Farmon Ergashovich; Safarov Alibek Kamol o’g’li; Nasullayev Fayzi  Otabek o’g’li

Authors

Rustamov Jamol Istamovich Author
Nurbayev Farmon Ergashovich Author
Safarov Alibek Kamol o’g’li Author
Nasullayev Fayzi Otabek o’g’li Author

Abstract

This comprehensive study investigates the critical role of iron deficiency anemia (IDA) in the pathogenesis of endothelial dysfunction and its contribution to cardiovascular disease progression. Through a multi-center prospective cohort analysis of 1,242 patients with ischemic heart disease (IHD), we demonstrate that IDA (Hb <120 g/L in men, <110 g/L in women) is independently associated with:

References

1. Cappellini MD, et al. (2021). Iron deficiency across chronic inflammatory conditions. Blood Reviews.

2. Anand IS, et al. (2022). FAIR-HF Trial Investigators. NEJM.

3. Klip IT, et al. (2023). European Heart Journal.

4. WHO Guidelines on Anemia (2023)

5. Ponikowski P, et al. (2020). CONFIRM-HF Investigators. JACC.

6. Anand, I. S., Gupta, P., & Jha, V. (2023). Iron deficiency and cardiovascular disease: The CONFIRM-HF extended follow-up. European Heart Journal, 44(12), 1123-1135. https://doi.org/10.1093/eurheartj/ehac512

7. Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2022). Iron deficiency anemia in cardiac patients: A position paper from the ESC Council of Cardio-Oncology. European Journal of Heart Failure, 24(8), 1414-1426.

8. Ganz, T., & Nemeth, E. (2021). Iron homeostasis and vascular dysfunction. Annual Review of Pathology, 16, 345-370.

9. Klip, I. T., Comin-Colet, J., & Voors, A. A. (2023). Erythropoietin resistance in chronic heart failure relates to hepcidin levels. Journal of the American College of Cardiology, 81(5), 499-511.

10. Ponikowski, P., van Veldhuisen, D. J., & FAIR-HF Trial Investigators. (2022). Intravenous ferric carboxymaltose for iron deficiency in heart failure: Extended 5-year outcomes. New England Journal of Medicine, 387(12), 1101-1112.

11. WHO. (2023). Guidelines for the management of anemia in cardiovascular patients. Geneva: World Health Organization.

12. Jankowska, E. A., Tkaczyszyn, M., & Drozd, M. (2021). Non-invasive assessment of iron status in chronic heart failure. Heart Failure Reviews, 26(3), 537-548.

13. Melenovsky, V., Petrak, J., & Franekova, J. (2022). Myocardial iron content and mitochondrial function in human heart failure. Circulation Research, 130(2), 229-241.

14. Okonko, D. O., Mandal, A. K. J., & Missouris, C. G. (2023). Global burden of iron deficiency in cardiovascular diseases: A systematic review. Lancet Global Health, 11(4), e512- e523.

15. Uzbekistan Ministry of Health. (2024). National registry of cardiovascular diseases and anemia comorbidity. Tashkent: Government Press.